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ABSTRACT The all-or-none kinetic model that we recently proposed for the antimicrobial peptide cecropin A is tested here for
magainin 2. In mixtures of phosphatidylcholine (PC)/phosphatidylglycerol (PG) 50:50 and 70:30, release of contents from lipid
vesicles occurs in an all-or-none fashion and the differences between PC/PG 50:50 and 70:30 can be ascribed mainly to differ-
ences in binding, which was determined independently and is ~20 times greater to PC/PG 50:50 than to 70:30. Only one variable
parameter, b, corresponding to the ratio of the rates of pore opening to pore closing, is used to ﬁt dye release kinetics from these
two mixtures, for several peptide/lipid ratios ranging from 1:25 to 1:200. However, unlike for cecropin A where it stays almost
constant, b increases ﬁve times as the PG content of the vesicles increases from 30 to 50%. Thus, magainin 2 is more sensitive
to anionic lipid content than cecropin A. But overall, magainin follows the same all-or-none kinetic model as cecropin A in these
lipid mixtures, with slightly different parameter values. When the PG content is reduced to 20 mol %, dye release becomes very
low; the mechanism appears to change, and is consistent with a graded kinetic model. We suggest that the peptide may be
inducing formation of PG domains. In either mechanism, no peptide oligomerization occurs and magainin catalyzes dye release
in proportion to its concentration on the membrane in a peptide state that we call a pore. We envision this structure as a chaotic
or stochastic type of pore, involving both lipids and peptides, not a well-deﬁned, peptide-lined channel.INTRODUCTION
We have recently proposed a very simple model for the
mechanism of cecropin A (1), which quantitatively explains
the experimental efflux kinetics data and is consistent with
the all-or-none release of vesicle contents induced by that
antimicrobial peptide. Essentially, the peptides bind to the
membrane and reside on its surface until a membrane break
point is reached. Then, the vesicle yields, releasing all its
contents at once, in what may be called a chaotic pore event
(2). The simplicity of the model is manifest by the need to
vary only one fit parameter, in addition to including the inde-
pendently measured binding and dissociation rate constants,
to reproduce experimental efflux data obtained in a variety
of lipid mixtures and concentrations.
In his comment, Axelsen (2) laid a challenge: how gener-
ally applicable is this model? Here we take up the challenge
in an important case. We test the validity of the model to
describe the mechanism of magainin 2, which is perhaps
the most studied of all antimicrobial peptides. The discovery
of magainins by Zasloff (3) had a profound impact on the an-
timicrobial peptide field. Most researchers believe that mag-
ainin functions through a toroidal pore model (4–6), but
much contradictory data exists. Part of the confusion arises
because different lipid model systems have been used by dif-
ferent authors, and transfer of conclusions from one system
to another is not always warranted. To avoid this problem,
we will be specific about experimental conditions when
referring to the literature.
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0006-3495/09/01/0116/16 $2.00Magainin decreases or dissipates the membrane potential of
several energy-transducing membranes (7,8). It stimulates
respiration at low concentration, but inhibits it at high con-
centration, and the effects are reversible (8). All-D-magainin
behaves identically to normal, all-L-magainin in terms of
secondary structure, antimicrobial activity, and hemolysis,
indicating that no stereochemically sensitive protein recep-
tors are involved in peptide recognition (9,10). Antimicrobial
activity is altered, significantly in some cases, by small
changes in the primary sequence of magainin 2, such as
deletion or substitution of a few residues, or C-terminal ami-
dation (11,12). Using cell fixation, magainin 2 was shown to
cross the bacterial cytoplasmic membrane (13).
Magainins also cause dye release from phospholipid ves-
icles (14,15). Pore formation by magainin 2 appears to occur
concomitantly with lipid flip-flop (5), although it is not clear
whether dithionite entering the vesicle is not actually respon-
sible for what appears to be lipid flip-flop. A continuous
measurement using the excimer/monomer ratio of a pyrene
lipid probe incorporated in the bilayer indicates that flip-
flop occurs in ~5 min at a peptide/lipid ratio (P/L) of 1:50
(16). Matsuzaki et al. (5) argued for a lipid/peptide pore on
the basis of a comparison between the rates of lipid flip-
flop and lipid diffusion across a curved region of the pore.
The effect of peptide charge on leakage of calcein from
egg phosphatidylcholine (PC)/phosphatidylglycerol (PG)
large unilamellar vesicles (LUVs) was examined (17) and
it was found that the analog F12W-magainin 2 (þ4 charge),
which behaves very similarly to magainin 2 (18), is more
efficient than one with a þ2 charge, which is in turn more
efficient that an analog with a þ6 charge. This indicates
that the activity of magainin 2 is not a monotonic function
doi: 10.1016/j.bpj.2008.09.017
Mechanism of Magainin 2 117of the peptide net charge. The effect of the nature of the
charged lipid species was also examined by comparing re-
lease from egg PG and bovine brain phosphatidylserine
(PS) vesicles (19). Dye release from the PG vesicles was
~10-fold faster, but it should be noted that the concentrations
of the two lipids differed by a factor of 10 in those experi-
ments. The activity of magainin, measured by calcein release
from LUVs, increases from 1-palmitoyl-2-oleoylphosphati-
dylcholine (POPC) to POPC/1-palmitoyl-2-
oleoylphosphatidylglycerol (POPG) 1:1, even more so for
POPC/POPG 3:1, and >100-fold for pure POPG (20). How-
ever, the selectivity of magainin analogs toward anionic
LUVs decreases as peptide hydrophobicity increases.
An interesting observation is that magainin 2a and PGLa,
another antimicrobial peptide, act synergistically in inducing
dye efflux from vesicles, especially in equimolar mixtures
of the two peptides (21,22) and, even more potently, as
cross-linked, fixed dimers (23,24). Furthermore, association
of PGLa and magainin drives insertion of PGLa into the
membrane (25).
The secondary structure of magainin is well established
by several different methods, including two-dimensional
1H-nuclear magnetic resonance (NMR) (26,27), Raman spec-
troscopy (21), 15N-chemical-shift solid-state NMR (28), and
circular dichroism (CD) (17,20,29). Magainin 2 is unstruc-
tured andmonomeric in aqueous solution but forms an amphi-
pathic a-helix (Fig. 1) in trifluoroethanol (TFE)/water
mixtures (26,27,29), bound to lipid membranes (21), or in
micelles of dodecylphosphocholine or sodium dodecylsulfate
FIGURE 1 Helical wheel projection of magainin 2. Solid symbols
represent basic residues; dark shading, acidic residues; light shading, hydro-
phobic residues; and open symbols, hydrophilic residues, according to the
water/octanol transfer scale (81).(27). The C-terminal amidated version, magainin 2a, is also
a-helical (28). The degree of helicity depends on the medium
(21), but it is usually close to 50% in TFE/buffer (29) and
zwitterionic, PC membranes (20,21), increasing to nearly
80% on POPC/POPG mixtures (20). However, the apparent
lower helical content in zwitterionic bilayers probably reflects
the lower degree of binding and not an intrinsic difference in
structure relative to anionic membranes. In TFE/buffer, vari-
ants ofmagainin 2a decrease in helicity as the charge increases
(0 > þ 2 > þ 4 > þ 6), while remaining monomeric (17).
The orientation of magainin relative to the membrane has
been much debated, a question closely related to the possible
formation of a toroidal pore. Magainin 2a was shown to be
oriented parallel to the membrane surface by 15N-chemi-
cal-shift solid-state NMR at P/L z 1:30 (26,28,30). Using
oriented CD (OCD) in membranes of dimyristoylphos-
phatidylcholine (DMPC)/dimyristoylphosphatidylglycerol
(DMPG) 3:1, Ludtke (31) found that at P/L% 1:60, the pep-
tide lies parallel to the membrane, but the orientation changes
to perpendicular at P/L > 1:30. However, this is not a sharp
transition and the two orientations coexist over a broad range
of P/L. Moreover, the threshold for change from parallel to
perpendicular orientation relative to the membrane surface
depends on the lipid. In POPC, even at P/L 1:20, OCD shows
that magainin lies parallel to the membrane and no pore peak
is observed in neutron scattering (4). In PC/phosphatidylser-
ine (PS) mixed membranes, binding of magainin 2a causes
membrane thinning by ~1 A˚ from pure lipid to P/L 1:100
(32). Neutron in-plane scattering in DMPC/DMPG 3:1,
which measures scatter due to D2O in the membrane plane,
shows a peak consistent with pores of ~20 A˚, which could
include 4–7 magainins, at P/L 1:20 (4). It has been shown
by 31P-solid-state-NMR (33) that the effect of magainin 2a
on PC vesicles depends on the lipid acyl chain (POPC or
DMPC), the lipid state, and the way lipid and peptide are
mixed. Nevertheless, Bechinger (33) has argued that the re-
sults are consistent with peptide surface association, parallel
to the membrane. Note that, in the work of Ludtke et al. (4),
in DMPC/DMPG 3:1, at P/L 1:20 only ~30–50% peptide
insertion occurs, which is consistent with NMR showing
mainly a parallel orientation (28,34). Synthetic magainin
2 mutants (F5W, F12W, and F16W) were shown to reside
close to the membrane/water interface by fluorescence
quenching (18). Photolabeling studies seem to indicate that
magainin 2 inserts in vesicles with 20% PG at P/L 1:30
(35), although some potential drawbacks inherent to the
method should be kept in mind. A parallel orientation of
magainin 2, even at P/L 1:30, was also inferred from the di-
chroism of the amide I band in Fourier transform infrared
spectroscopy (36).
A structure for a magainin toroidal pore was proposed
based on a regular hexagonal arrangement of pores observed
by x-ray diffraction (37). However, Mu¨nster et al. (38) found
no evidence for pore formation, as their x-ray diffraction
failed to indicate any lateral correlations between possibleBiophysical Journal 96(1) 116–131
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calorimetry (39) demonstrated that the magainin analog
MSI-78 increases the liquid crystalline-to-hexagonal (La–HII)
transition temperature of dipalmitoylphosphatidylethanol-
amine, as does magainin 2 (19). MSI-78 also inhibits the
La–HII transition of 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphatidylethanolamine (POPE) (by 31P-NMR), suggest-
ing that it induces positive curvature strain, but no HI phase
is induced even at 10–15% peptide. In POPC, the peptide in-
duced changes in bilayer structure even at 1–5%, and HI
phase appeared at 10–15% peptide. Hallock et al. (39) inter-
preted these results as lending support to the toroidal pore
model. However, the sinking raft model is also consistent
with those data (40).
The questions of oligomerization of magainin 2 and, in
particular, its possible dimerization have also been ad-
dressed by many researchers. Early work (8) suggested
that an oligomeric pore is the active form, while most pep-
tide remains monomeric. This was based on a logarithmic
plot of the peptide concentration required for half-maximal
stimulation of cell respiration, which indicated a cooperativ-
ity parameter of n ¼ 5. Matsuzaki et al. (18) argued for
dimerization of magainin 2 based on binding isotherms,
which were, however, obtained in an indirect way. But
Schu¨mann et al. (41) observed no dimerization or oligomer-
ization on the membrane surface, using fluorescence reso-
nance energy transfer (FRET) from F16W-magainin 2a to
n-dansyl-magainin 2a. Moreover, binding isotherms ob-
tained with isothermal titration calorimetry (ITC) do not
indicate cooperativity, arguing against peptide oligomeriza-
tion (42). A magainin 2 analog (F5Y,F16W) forms an
antiparallel dimer, mostly helical, when bound to dilauroyl-
phosphatidylcholine (DLPC) small unilamellar vesicles
(SUVs), as determined by transferred nuclear Overhauser
enhancement NMR, at 5 mM peptide and 0.5 mM lipid
(43). Since the equilibrium dissociation constant, KD, for
binding to POPC SUVs is ~200 mM (42), the vesicles
should be almost covered with peptide. The dimer seems
to be stabilized by an aromatic lock or zipper. However,
the peptide hydrophobic surface left exposed is small and
it is not clear how the dimer would bind to a membrane.
The dimer position relative to the membrane surface was
not determined. A phenylalanine zipper was also found
by NMR for a dimer of MSI-78, a peptide similar to mag-
ainin (44). With 3 mol % peptide in POPC and POPC/
POPG 3:1 bilayers, the MSI-78 peptides are helical. How-
ever, another analog, MSI-594, which contains the breaker
sequence GIG, is less compact. MSI-78 forms a dimer in
dodecylphosphocholine micelles, but MSI-594 is mono-
meric. These observations underscore the importance of
detailed sequence in fine-tuning the peptide conformation
and indicate that even conservative mutations do not neces-
sarily produce peptides with similar behavior.
Thus, contradictions remain regarding the mechanism of
magainin. Perhaps the most important concerns oligomeriza-
Biophysical Journal 96(1) 116–131tion, because whether it occurs is essential for the mechanism
of pore formation. If a toroidal pore forms, is its structure
determined by intermolecular interactions between the pep-
tides? Or do several peptides simply migrate to a pore that
is already forming in the membrane? In the former case, pep-
tide oligomerization is a required step for pore formation. In
the latter, this is not necessary and magainin could follow the
same model as cecropin A (1). The mechanism of magainin 2
is investigated here in a model membrane system consisting
of LUVs of POPC/POPG mixtures. These mixtures have
been widely used to mimic bacterial lipids and do in fact re-
semble the lipid composition of some bacterial membranes
(45,46). However, model membranes are not bacterial cells
and additional factors play a role in the biological function
of antimicrobial peptides. For example, in Gram-negative
bacteria, the presence of lipopolysaccharide, a major compo-
nent in the outer membrane (45), has important implications
for peptide function (47). Nevertheless, there is no alterna-
tive to using model membranes in quantitative kinetic anal-
yses, and we have concentrated on phospholipid mixtures
whose behavior is well understood. To rigorously test the
model proposed (1), it was necessary to measure the kinetics
of magainin 2 binding, dissociation, and induced dye release,
as well as to conclusively establish the mechanism of dye re-
lease (graded or all-or-none). In the end, we arrive at impor-
tant conclusions regarding the mechanism of magainin,
which we hope will contribute to resolving some of the
apparent contradictions in the field. Recognizing possible
mechanisms in well-characterized membrane systems
through the use of quantitative models of peptide function
that are simple enough to be useful is a first step—though
not the final—to understand their function in bacterial
membranes.
METHODS
Chemicals
Magainin 2 (GIGKFLHSAKKFGKAFVGEIMNS) was purchased from
American Peptide (Sunnyvale, CA). A stock solution was prepared by
dissolving lyophilized peptide in deionized water/ethyl alcohol 1:1 (v/v)
(AAPER Alcohol and Chemical, Shelbyville, KY). Stock peptide solutions
were stored at 20C, and kept on ice during experiments. 1-Palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glyc-
ero-3-phosphatidylethanolamine (POPE), and 1-palmitoyl-2-oleoyl-sn-glyc-
ero-3-[phospho-rac-(1-glycerol)] (POPG), in chloroform solution, were
purchased from Avanti Polar Lipids (Alabaster, AL). 7-Methoxycoumarin-
3-carboxylic acid (7MC), 1-[[(6,8-difluoro-7-hydroxy-4-methyl-2-oxo-2H-
1-benzopyran-3-yl)acetyl]oxy] (Marina Blue (trademark), MB) succinimidyl
ester, 4-chloro-7-nitrobenz-2-oxa-1,3-diasole (NBD) chloride, 8-aminonaph-
talene-1,3,6-trisulfonic acid (ANTS) disodium salt, and p-xylene-bis-pyridi-
nium bromide (DPX) were purchased from Molecular Probes/Invitrogen
(Carlsbad, CA). Carboxyfluorescein (CF, 99% pure, lot No. A015252901)
was purchased from ACROS (Morris Plains, NJ). Organic solvents (High
Performance Liquid Chromatography/American Chemical Society grade)
were purchased fromBurdick& Jackson (Muskegon,MI). Lipids and fluoro-
phores were tested by thin layer chromatography and used without further
purification.
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The syntheses of fluorescent probes, using POPE and a fluorophore attached
through an amide bond to the amino group of the ethanolamine headgroup,
were performed as previously described in detail for NBD-POPE and
MB-POPE (48), and for 7MC-POPE (1), following the method of Vaz and
Hallmann (49).
Preparation of large unilamellar vesicles
Large unilamellar vesicles (LUVs) were prepared by mixing the lipids in
chloroform in a round-bottom flask, followed by rapid evaporation of the
solvent in a rotary evaporator (model No. R-3000; Bu¨chi Labortechnik,
Flawil, Switzerland) at 60–70C. The lipid film was then placed under
vacuum for 4 h and hydrated by the addition of buffer containing 20 mM
3-(N-morpholino) propanesulfonic acid (MOPS), pH 7.5, 0.1 mM EGTA,
0.02% NaN3, and 100 mM KCl or appropriately modified as indicated be-
low. In the modified buffers, containing CF or ANTS/DPX, the KCl concen-
tration was adjusted to yield the same measured osmolarity as in this buffer.
The suspension of multilamellar vesicles that form was subjected to five
freeze-thaw cycles and extruded 10 through two stacked polycarbonate fil-
ters of 0.1 mm pore size (Nuclepore; Whatman, Florham, NJ) using a water-
jacketed high pressure extruder (Lipex Biomembranes, Vancouver, Canada)
at room temperature. For membranes containing MB-POPE, NBD-POPE, or
7MC-POPE, the probes were added in chloroform solutions together with
the lipids. Lipid concentrations were assayed by the Bartlett phosphate
method (50), modified as previously described (51).
Membrane association and dissociation kinetics
To measure association of magainin 2 with membranes by FRET, F12W-
magainin 2 was used. This analog, in which Phe-12 is replaced by Trp,
behaves very similarly to the original magainin 2 (17,18). The kinetics of as-
sociation of F12W-magainin 2 with LUVs were recorded on a stopped-flow
fluorimeter (model No. SX.18MV; Applied Photophysics, Leatherhead, Sur-
rey, UK). FRET between the Trp residue of the peptide and the lipid fluoro-
phore 7MC-POPE incorporated in lipid membrane was used to monitor
peptide binding and dissociation from LUVs as previously done for cecropin
A (1). Trp excitation was at 280 nm and the emission of 7MC (maximum at
396 nm) was measured using a cutoff filter (model No. GG-385; Edmund
Industrial Optics, Barrington, NJ). After mixing, the concentration of
peptide was 1 mM and the lipid varied between 25 and 400 mM.
ANTS/DPX assay
Steady-state fluorescence measurements were performed in a spectrofluorim-
eter (model No. 8100; SLM-Aminco, Urbana, IL) upgraded by ISS (Cham-
paign, IL). In the ANTS/DPX assay (52–54), excitation was at 365 nm (8 nm
slit-width) and emission at 515 nm (16 nm slit-width). The solution encap-
sulated in the LUVs contained 5 mM ANTS, 8 mM DPX, 20 mM MOPS,
pH 7.5, 0.1 mMEGTA, 0.02%NaN3, and 70 mMKCl. The titrating solution
contained 45 mM DPX, 20 mM MOPS, pH 7.5, 0.1 mM EGTA, 0.02%
NaN3, and 30 mM KCl. After extrusion, the LUVs with encapsulated
ANTS and DPX were passed through a Sephadex-G25 column to separate
the dye in the external buffer from the vesicles. Typical concentrations
were ~0.1–2 mM peptide and 500 mM lipid.
CF efﬂux experiments
Carboxyfluorescein (CF) efflux kinetics were measured as described before
(1,40,55). Briefly, LUVs were prepared by hydration of the lipid film in
20 mM MOPS buffer, pH 7.5, containing 0.1 mM EGTA, 0.02% NaN3,
and 50 mMCF, to give a final lipid concentration of 10 mM. After extrusion,
CF-containing LUVs were passed through a Sephadex-G25 column to
separate the dye in the external buffer from the vesicles. For fluorescencemeasurements, the suspension was diluted to the desired lipid concentration
in buffer containing 20 mM MOPS, pH 7.5, 100 mM KCl, 0.1 mM EGTA,
and 0.02% NaN3. The kinetics of CF efflux, measured by the relief of self-
quenching of CF fluorescence, were recorded in a spectrofluorimeter (model
No. 8100, SLM-Aminco) upgraded by ISS, with excitation at 470 nm and
emission at 520 nm. The fastest curves were recorded using a stopped-
flow fluorimeter (model No. SX.18MV, Applied Photophysics), with excita-
tion at 470 nm and emission recorded through a long-pass filter (model No.
OG 530; Edmund Industrial Optics). The peptide concentration was 1 mM
after mixing, in all experiments. The fraction of CF released was determined
by comparison of the fluorescence with that obtained upon addition of Triton
X-100, which releases all the dye.
Analysis of binding kinetics
The kinetics of magainin binding to membranes was analyzed as previously
described in detail for cecropin A (1). Briefly, reversible binding of peptides
to lipid vesicles is described by
kon½L
Pw#PL;
koff
(1)
where Pw represents peptide in water; L, lipid vesicles; PL, peptide bound
to the membrane; and kon and koff are the on- and off-rate constants. The
time courses of binding and dissociation are then described by
PLðtÞ ¼ A0

1 ekappt þ A1; (2)
PwðtÞ ¼ B0ekappt þ B1; (3)
where the apparent rate constant is given by
kapp ¼ kon½L þ koff (4)
and A0, A1, B0,and B1 are constants. In these equations, [L] is the vesicle con-
centration (related to the lipid concentration by 1 LUVx 105 lipids), which
is considered constant because the number of peptides bound per vesicle is
always small, and vesicles do not disappear when peptides bind. The binding
kinetics were analyzed using Eq. 2. The apparent rate constants, obtained
from single-exponential fits to the experimental binding kinetic curves,
were plotted against the lipid concentration, yielding a linear plot with slope
kon and y intercept koff (Eq. 4).
Analysis of dissociation kinetics
The dissociation kinetics experiment (1) is represented by
koff k
0
on½L0
PL # Pw / PL0 ;
kon½L
(5)
where peptide (PL) initially bound to donor vesicles (L) dissociates and irre-
versibly binds to acceptor vesicles (L0). In the experiment, the donors are
mixed vesicles of POPC/POPG, whereas the acceptors are pure POPG.
Since the affinity of magainin for pure POPG is much greater than for
POPC/POPG mixtures and the acceptors are in excess, irreversible peptide
binding to the acceptors is assumed. As previously shown (1), the kinetics
corresponding to this process follow a decay function with a main apparent
rate constant (k0app) that is a function of kon, koff, k0on, and the concentrations
of vesicles. If the concentration of donors is decreased keeping the concen-
tration of acceptors constant, a set of values of k0app is obtained that closely
approach the real koff (1). A plot of k
0
app against the donor lipid concentra-
tion, [L], yields a y intercept that is a good estimate of koff.
When F12W-magainin 2 dissociates from the donor vesicles, energy
transfer from its Trp to 7MC-POPE on the membrane decreases, resulting
in a decay of the fluorescence emission of 7MC-POPE as a function ofBiophysical Journal 96(1) 116–131
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expected behavior from the simple description provided by Eq. 5 is a single-
exponential decay function of the form of Eq. 3 (1). In some cases, however,
a double-exponential decay was necessary to obtain a good fit. This must
correspond to deviations from the simple behavior represented by Eq. 5.
Rather than using a more complicated analysis in those cases, k0app was
obtained from the apparent mean lifetime (t) defined by (56,57)
t ¼
Z
d FðtÞ
dt
t dt
Z
d FðtÞ
dt
dt; (6)
k0app ¼ 1=t; (7)
which is equivalent to an amplitude-weighted average of the time constants
in a multiexponential decay. All curves could be reasonably well fit with, at
most, a double-exponential decay with amplitudes a and (1  a), corres-
ponding to a mean lifetime t ¼ at1 þ (1  a)t2.
Analysis of CF efﬂux kinetics
Two models were used to analyze the CF efflux data. The first was the model
we previously proposed for the mechanism of all-or-none dye release
induced by cecropin A (1). This model, illustrated in Fig. 2 (left), was tested
for magainin 2 through analysis of CF efflux kinetics. A detailed account
of the model, including its expression as a set of differential equations, its
constraints, and assumptions, was given in detail in our previous article
(1). Briefly, there are four states in this model:
1. Peptide as an unstructured monomer in water.
2. Peptide bound, as an a-helix, to the membrane surface of full vesicles.
FIGURE 2 Models proposed for the mechanisms of peptides that cause
all-or-none release (left) and peptides that cause graded release (right).
The peptide is represented as unstructured in aqueous solution, in accor-
dance with experiment. When bound to the membrane, it forms an a-helix,
which is shown in cross section as a cylinder, where the darker half-circles
represent the hydrophobic faces and the lighter represent the hydrophilic
faces. All-or-none model (1): (A) peptide in solution; (B) peptide bound to
the membrane surface of dye-loaded vesicles; (C) peptide associated with
vesicles in the pore state, which causes efflux in an all-or-none manner;
and (D) peptide bound to an empty vesicle, from which it dissociates back
into solution. The on- and off-rate constants are fixed from the independently
measured binding and dissociation kinetics. (Reproduced, with modifica-
tions, from Gregory et al. (1) with permission from Biophys. J.) Graded
model (40,55): Binding of peptides creates a mass imbalance across the lipid
bilayer, which perturbs the membrane thus enhancing the probability of
a peptide transiently inserting into the hydrophobic core and eventually
crossing the bilayer. In the bilayer-inserted state, the peptide catalyzes dye
efflux from the vesicle lumen; this state constitutes the apparent pore. As
peptide translocation is completed, the mass balance across the bilayer is
restored and the rate of efflux becomes very slow or eventually stops.
(Reproduced, with modifications, from Yandek et al. (55) with permission
from Biophys. J.)
Biophysical Journal 96(1) 116–1313. Peptide in the pore state of the vesicles.
4. Peptide bound to empty vesicles.
The rate constants kon and koff describe binding to, and dissociation from
vesicles (full or empty). Then, there is a certain probability, proportional to
a rate constant k1, that a vesicle with surface-associated peptides will enter
a pore state; at this point, the membrane yields and all dye is released.
The pore state is unstable and relaxes to an empty vesicle state with a rate
constant k2. The peptide can dissociate from the membrane and bind to an-
other vesicle, continuing the cycle of vesicle permeabilization. Efflux occurs
from the pore state (P*) and is described by another rate constant, keflx. The
efflux rate observed macroscopically, expressed as the increase in the frac-
tion of CF outside, is the product of three factors: keflx; the concentration of
peptides in the pore state of the vesicle per unit of lipid membrane P*/[L];
and the fraction of vesicles still full of CF (1).
In the analysis of CF efflux, kon and koff were fixed at the values obtained
from the binding and dissociation kinetics. Furthermore, to stringently test
this model, the rate constants for formation of the pore state (k1) and the
efflux rate constant (keflx) were fixed at the same values used for cecropin
A (1). Thus, k2 was the only parameter allowed to vary. This is equivalent
to varying the ratio k1/k2, which we call b. The rate constant for pore relax-
ation, k2, was adjusted by requiring that one value globally fit the CF efflux
kinetics for all lipid concentrations pertaining to each lipid composition.
Then, a slight variation of k2 was allowed within each lipid composition
to better fit the curves for the different lipid concentrations individually,
and to obtain an estimate of the error. The mean values of b obtained
from those fits and their corresponding standard deviations are listed in
Table 1. In addition, an amplitude factor (0.8–1.1) was allowed for each
curve, which corrects for experimental error in the determination of the
maximum dye release.
The second model (Fig. 2, right) was previously proposed for transportan
10 (tp10), which is a cell-penetrating peptide that causes graded dye release
(55). The detailed mathematical description of this model was presented by
Yandek et al. (55) and is not repeated here. We note only that the apparent
rate constant for insertion kins depends on the difference between the concen-
trations ([P]) of peptide bound to the outer and inner leaflets of the lipid
bilayer, kins ¼ kins j½Pouter  ½Pinnerj, where k*ins is a true rate constant.
Thus, efflux stops when the bound peptide concentration is the same on
both sides of the bilayer. The analysis was subject to similar constraints as
used for the all-or-none model.
The differential equations were solved by numerical integration with
a fifth-order Runge-Kutta method with constant step size (58), and the
numerical solutions were fit directly to the experimental data with a simplex
algorithm (58) on a Linux workstation with in-house FORTRAN code
programs, using the f95 compiler (Numerical Algorithms Groups, Oxford,
UK).
For the CF efflux reverse experiment, where donor (empty) vesicles
were preequilibrated with magainin, the initial conditions were calculated
from the integrated equations in the forward reaction, for a period equal to the
preincubation time of magainin with empty vesicles, as before (1,40,55).
RESULTS
Binding and dissociation kinetics
The kinetics of magainin 2 binding to lipid vesicles weremea-
sured by stopped-flow fluorescence, using the variant peptide
F12W-magainin 2, which behaves similarly to magainin (18).
Upon F12W-magainin 2 binding to the membrane, FRET oc-
curs from the Trp residue to a lipid fluorophore incorporated
in the bilayer, 7MC-POPE, and the resulting increase in
fluorescence emission intensity of 7MC-POPE was used to
monitor the binding kinetics (Fig. 3, left). The curves
obtained were well fit by a single-exponential function
Mechanism of Magainin 2 121TABLE 1 Magainin 2 on- and off-rate constants, equilibrium dissociation constants, and pore formation/relaxation ratio (b)
for POPC/POPG vesicles
Vesicle composition Binding kinetics Dissociation kinetics Dissociation constant* Pore state
POPC/POPG kon (M
1 s1) koff (s
1) koff (s
1) KD (mM) b ¼ k1/k2
50:50 (9.15 0.4)  105 205 9 1.655 0.12 1.8 b ¼ (9.85 1.4)  104
70:30 (8.55 0.7)  105 775 14 305 4 35 b ¼ (2.25 0.9)  104
80:20 (7.85 0.7)  105 1605 15 885 3 110 kdins ¼ 505 20 s1
90:10 (5.55 0.9)  105 3505 20 2005 8 370 —
100:0y 9.7  104 600 500 5000 —
The rate constants were obtained from the fits of experimental kinetics to the model. The error is estimated from the fits using the linear regression (kon and koff)
or the variance in fitting the individual curves (b). The two other rate constants in the model were held fixed (keflx ¼ 100 M1 s1 and k1 ¼ 0.01 s1).
*Calculated using kon from binding and koff from dissociation kinetics.
yEstimated by extrapolation (Fig. 5).(Eq. 2), yielding the value of the apparent rate constant (kapp).
Tucker et al. (59) obtained kinetic association curves using
a different magainin analog, which they fit with a double
exponential. However, in most cases, ~90% of the amplitude
in their fits corresponded to one of the two exponentials,
essentially agreeing with our results. A plot of kapp against
lipid concentration yields a linear fit (Fig. 3, right) in whichthe y intercept is koff and the slope is kon (Eq. 4). The rate con-
stants for F12W-magainin 2 binding to, and dissociation from
membranes of POPC/POPG 50:50, 70:30, 80:20, and 90:10
were obtained from those fits; they are listed in Table 1 and
plotted later in Fig. 5 A.
The value of koff obtained from the binding kinetics can
have a considerable error if the y intercept occurs close toFIGURE 3 Kinetics of magainin 2 binding to vesicles of
POPC/POPG 50:50 (A and B), 70:30 (C and D), 80:20 (E
and F), and 90:10 (G andH). The signal recorded as a func-
tion of time is the FRET from Trp on the peptide to the lipid
probe 7MC-POPE incorporated in the bilayer. On the left,
the shaded curves are experimental traces recorded with
25 mM lipid and 1 mM F12W-magainin 2 (~10 traces
were averaged to improve the signal/noise ratio); the solid
line is a single-exponential fit to the data (Eq. 2). On the
right, the apparent rate constant (kapp) is plotted against
lipid concentrations to obtain kon from the slope and koff
from the y intercept (Eq. 4).
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experiment was also performed. F12W-magainin 2 was pre-
incubated with vesicles of POPC/POPG 50:50, 70:30, 80:20,
and 90:10 containing 1 mol % 7MC-POPE (donors), which
were then mixed in the stopped-flow system with pure POPG
vesicles containing no probe (acceptors). Because binding of
magainin is much stronger to pure POPG, once dissociation
from the donors occurs, the peptide binds mainly to the ac-
ceptors. To render the process quasiirreversible, the concen-
tration of acceptors (500 mM) was always larger than that of
donors (50–300 mM). Fig. 4 shows representative kinetic
curves for the various lipid compositions examined (left),
and plots of the apparent off-rate constants (k0app) against
donor lipid concentration (right). These plots exhibit the
expected lipid concentration dependence and, as the donor
concentration approaches zero, k0app approaches koff (1).
The off-rate constants thus obtained are also listed in Table 1.
The kinetic curves in the dissociation experiment deviate
more noticeably from a single exponential and the k0app re-ported is a weighted average (Eq. 7). These values are similar
to those obtained for koff in the binding kinetics, though
generally smaller by a factor of ~2, a slight discrepancy
also observed for cecropin A (1). As then, we used the values
obtained from the dissociation experiment to calculate KD
because this measurement is more direct. However, a fac-
tor-of-2 difference in koff has no effect on the analysis of
efflux data and the values obtained from both methods
have the same PG concentration dependence (Fig. 5 B).
Clearly, as the POPG content of the vesicles increases, koff
decreases sharply from ~500 s1 for pure POPC to ~1 s1
for POPC/POPG 50:50.
Binding of magainin to pure POPC was known to be weak
(29) and, indeed, kon and koff could not be determined from
the binding kinetics. Therefore, those rate constants were es-
timated by extrapolating to pure POPC the values of kon and
koff obtained for POPC/POPG mixtures as a function of
POPC content (Fig. 5), and are also listed in Table 1. The
equilibrium dissociation constant, KD ¼ koff/kon z 5 mM,FIGURE 4 Kinetics of F12W-magainin 2 dissociation
from vesicles of POPC/POPG 50:50 (A and B), 70:30 (C
and D), 80:20 (E and F), and 90:10 (G and H). The signal
recorded as a function of time is the FRET from Trp on the
peptide to the lipid probe 7MC-POPE incorporated in the
bilayer. Peptide, at a concentration of 2 mM, was incubated
with 100–600 mM of POPC/POPG 50:50, 70:30, and
80:20, for 30, 40, and 60 min, respectively, and then mixed
in the stopped flow with 1 mM POPG LUVs. The concen-
trations after mixing are half of those values. On the left,
the shaded curves represent dissociation kinetics recorded
with 50 mM donor lipid and 1 mM F12W-magainin 2
(~10 traces were averaged to improve the signal/noise
ratio); the solid line is a one- or two-exponential fit to
the data. On the right, the k0app obtained from those fits is
plotted against the concentration of donor lipid to obtain
koff from the y intercept (limit of zero donors).
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Mechanism of Magainin 2 123confirms the very weak binding to pure POPC vesicles. KD
increases exponentially with the POPC content of the
membrane (Fig. 5 C).
Mechanism of dye release
Two mechanisms are possible for peptide-induced dye re-
lease from lipid vesicles: all-or-none, in which some vesicles
lose all of their contents while others are not affected; or
graded, in which all vesicles lose part of their contents.
The mechanism of dye release by magainin 2 was deter-
mined using the ANTS/DPX assay (52–54). A fluorophore,
ANTS, is encapsulated in the vesicles together with
a quencher, DPX. The fluorescence from ANTS released
FIGURE 5 (A) On- and (B) off-rate constants, and (C) equilibrium
dissociation constant for F12W-magainin 2 as a function of the POPC
content in POPC/POPG mixtures. The open circles are from binding
kinetics (Fig. 3) and the squares are from dissociation kinetics experiments
(Fig. 4).by the peptide to the external solution is titrated by additional
DPX and subtracted out. As ANTS and DPX leak out at
comparable rates, the fluorescence from ANTS remaining
inside the vesicles increases. This is because quenching of
ANTS fluorescence by DPX is a bimolecular process and
therefore strongly dependent on quencher concentration. In
all-or-none release, the degree of quenching inside the vesi-
cles is independent of the amount of ANTS and DPX
released because only the intact vesicles contribute to the
inside signal. In graded release, the fluorescence of ANTS
in the vesicles increases because the quencher concentration
inside decreases. The assay was performed for magainin 2
with vesicles of POPC/POPG 50:50, 70:30, and 80:20. The
experimental data for POPC/POPG 50:50 and 70:30 are in-
distinguishable and clearly show that magainin 2 induces
all-or-none release (Fig. 6, solid circles). As the fraction of
fluorescence outside (fout) of the vesicles increases, the fluo-
rescence from within the vesicles remains the same (Qin),
resulting in a horizontal line. The dependence on fout that
would correspond to graded release is given qualitatively
by the dashed line in Fig. 6. For POPC/POPG 80:20 (open
circles) a conclusion cannot be reached because dye release
is very limited, even at long times.
To ensure that the all-or-none dye release observed for
POPC/POPG 50:50 and 70:30 was not an artifact of vesicle
fusion, the ANTS/DPX assay was repeated with 10-fold
lower concentrations of both lipid and peptide because
fusion is less likely at lower lipid concentrations. The data
had more scatter because of the small concentrations, but
FIGURE 6 ANTS/DPX assay to determine the mechanism of release by
magainin 2. The quenching function inside,Qin¼ Fi/Fimax, which is the ratio
of ANTS fluorescence inside the vesicle in the presence (Fi) and absence
(Fi
max) of quencher (DPX), is plotted against the ANTS fraction outside
the vesicles, fout, corrected for incomplete entrapment as described by Lado-
khin et al. (54). The horizontal solid line is the result expected for all-or-none
release and the dashed line is for graded release. The data points correspond
to experiments on five independent vesicle preparations. Solid symbols cor-
respond to mixtures of POPC/POPG 50:50 and 70:30; open symbols, to
80:20. Because there are slight variations in the degree of encapsulation in
different preparations, the Qin data were first normalized to the average
initial fluorescence (in the absence of peptide), to bring all data sets to
a common origin. The standard deviations for Qin and fout were calculated
for each group of data points and are shown as error bars.Biophysical Journal 96(1) 116–131
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dition, we directly tested for peptide-induced vesicle fusion
using the assay previously described for cecropin A (1).
Briefly, two suspensions of vesicles labeled either with
a FRET donor (MB-POPE) or an acceptor (NBD-POPE),
were mixed in equal amounts. If fusion occurred upon addi-
tion of magainin to this suspension, energy transfer would be
expected, but none was observed. As a control, peptide was
added to vesicles labeled with both donor and acceptor
probes at half the concentration, in which case energy trans-
fer was observed. The results (not shown) closely parallel
those obtained with cecropin A (1). Thus, as also shown
by others (15,19), magainin 2 does not cause significant ves-
icle fusion. In conclusion, our results demonstrate that mag-
ainin 2 induces all-or-none release from vesicles of POPC/
POPG 50:50 and 70:30, in agreement with data from other
researchers (15,17,60,61).
CF efﬂux kinetics
Addition of magainin 2 to phospholipid vesicles with encap-
sulated CF causes dye efflux. Since CF was encapsulated at
high, self-quenching concentrations, its release from the ves-
icle lumen is accompanied by an increase in fluorescence,
which was used to monitor the efflux kinetics. Magainin 2
(1 mM) was mixed with LUVs, varying the lipid concentra-
tion from 25 to 200 mM, and the kinetics of dye efflux were
monitored. This experiment was performed for pure POPC
and POPG (Fig. 7), and for mixtures of POPC/POPG
50:50, 70:30, and 80:20 (Fig. 8, top panels). Very little efflux
occurs from pure POPC (Fig. 7, solid line), while efflux from
POPG is fast (Fig. 7, dashed line). If the POPG content in
a POPC matrix is increased, the efflux rate also increases
(Fig. 8, top, shaded curves). Furthermore, as the lipid con-
centration increases, the efflux rate decreases, because the
number of peptides bound per vesicle decreases.
FIGURE 7 Carboxyfluorescein efflux induced by magainin 2 from vesi-
cles of pure POPC, (solid line) and pure POPG (dashed line). In both cases
the peptide concentration is 1 mM and the lipid concentration is 25 mM. The
maximum possible fluorescence levels were determined by adding 1%
Triton X-100 to the vesicles.
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verse experiment was carried out: the efflux kinetics were
measured after magainin 2 was preincubated for ~1 h with
empty vesicles (donors), which were then mixed with vesi-
cles containing CF (acceptors). Now, magainin must dissoci-
ate from the donor vesicles, back into solution, before it can
bind to the acceptors and induce CF release. This experiment
was performed for POPC/POPG 50:50, 70:30, and 80:20, the
lipid composition of donor and acceptor vesicles being iden-
tical in each case (Fig. 8, bottom panels, shaded curves). The
CF efflux kinetics in the reverse experiments are very similar
to those in the direct addition experiments for the same lipid
and peptide concentrations (compare bottom panels with the
50 mM lipid curves in top panels). Thus, after incubation
with empty vesicles, magainin causes CF release from the ac-
ceptors almost as if it were directly added to the full vesicles.
Using the dissociation constants determined here (Table 1),
we calculated that only ~38% of the peptide is bound after
the preincubation in POPC/POPG 80:20, but ~97% of the
magainin is bound in POPC/POPG 50:50. This indicates
that the peptides can readily desorb from the donors and
bind to the acceptors. This experiment provides an important
constraint in the analysis below.
Analysis of CF efﬂux kinetics
The major goal of this work was to test whether magainin
conforms to the same model for all-or-none efflux as cecro-
pin A (1). To do this, we sought to independently fix as many
parameters in the model as possible. The on- and off-rate
constants for binding of magainin to vesicles were indepen-
dently determined and kept fixed in the fits to the CF efflux
kinetics. In addition, the rate constants for efflux (keflx ¼ 100
M1 s1) and formation of the pore state (k1 ¼ 0.01 s1)
were also fixed, at the same values used for cecropin A
(1). Thus, as before, only the value of k2 was adjusted by fit-
ting to the experimental efflux kinetics for a series of differ-
ent lipid concentrations and three vesicle compositions,
POPC/POPG 50:50, 70:30, and 80:20. As shown by the solid
lines in Fig. 8, the model was able to describe very well the
efflux curves for POPC/POPG 50:50 Fig. 8, A and B) and
70:30 (Fig. 8, C and D), in a global manner, for all lipid con-
centrations in the direct addition experiments and the reverse
experiment. A slight deviation of the fit from the experimen-
tal trace occurs at the beginning of some curves, suggesting
that perhaps a detail is missing from the model, but overall
this simple model captures the essence of the mechanism
of magainin. The fits can be characterized by the parameter
b¼ k1/k2, which gives the ratio of the rates of pore formation
to relaxation. It should be noted, however, that b is not an
absolute measure but depends on keflx, which we kept at
the same value used for cecropin A (1). Unlike for cecropin,
where it stays almost constant, b increases ~5 as the PG
content of the vesicles increases from 30 to 50 mol %.
Thus, magainin 2 is more sensitive to anionic lipid content
Mechanism of Magainin 2 125FIGURE 8 Carboxyfluorescein efflux from POPC/POPGmixtures induced by direct addition of magainin (top panels) to POPC/POPG 50:50 (A), 70:30 (C),
and 80:20 (E). In each top panel, the shaded curves correspond to lipid concentrations of 25, 50, 100, and 200 mM lipid (200 mM absent in E). The fastest curve
is always that for 25 mM lipid and the slowest is that for 200 mM lipid; the peptide concentration is always 1 mM. The bottom panels show the CF efflux reverse
experiments for the same vesicle compositions (shaded curves): POPC/POPG 50:50 (B), 70:30 (D), and 80:20 (F). Here, 60 mM donor vesicles containing no
CF were incubated with 2 mM peptide for 45, 60, and 90 min for POPC/POPG 50:50, 70:30, and 80:20, respectively. After incubation, the (empty) donor
vesicles were mixed with an equal volume of 40 mM, CF-containing acceptor vesicles in the stopped-flow system, resulting in final 50 mM lipid and
1 mM peptide concentration. The maximum possible fluorescence levels were determined by adding 1% Triton X-100 to the vesicle suspension. In all panels,
the curves shown are averages of approximately four independent traces recorded on the same vesicle preparation. In addition, the data was reproduced at least
twice in independent vesicle preparations. The solid lines in panels A–D are the fits of the all-or-none model (Fig. 2, left); the solid lines in panels E and F are
fits of the graded model (Fig. 2, right). For the all-or-none model, only one parameter was allowed to vary, b ¼ k1/k2, which is given in Table 1. The fits also
used the values of kon and koff independently obtained from the binding and dissociation kinetics.than cecropin A. The values of b obtained are listed in
Table 1. A variant of this model in which a magainin dimer
forms as a necessary step to causing efflux was also tried, but
produced very poor fits. Thus, magainin dimerization is
inconsistent with the dye efflux kinetics.
For POPC/POPG 80:20, however, it was impossible to fit
the curves, even relaxing all parameters in the model. The
shape of the curves is simply incompatible with the model.
The very small amount of dye released implies a halt in
the permeabilization process that this all-or-none model can-
not describe. A number of different all-or-none models were
then tried, introducing variations that could, in principle, al-
low us to fit the data. Among these variations, two performed
best. In the first, the peptide forms a nonproductive state, for
example an aggregate, which does not lead to efflux and
competes with the productive, pore-forming state, leading
in time to a stop of the efflux. In the second, the peptide
has an additional, silent mode of crossing the bilayer, that
is, one that does not induce efflux. This variation follows
a suggestion from Rathinakumar and Wimley (62). These
two models, which contain two additional free parameters
each, could fit the data in the direct reaction very well butcould not fit the reverse experiment at all. Note that the
reverse experiment (Fig. 8 F) shows efflux kinetics that are
almost identical to those obtained by direct addition of the
peptide to lipid with the same concentration (50 mM,
Fig. 8 E, middle curve). In POPC/POPG 80:20, after the pre-
incubation period, ~60% of magainin is in solution but the
remaining 40% must desorb so quickly from the donors
that they behave as if added from solution to the new, CF-
loaded, acceptors. Many other all-or-none models were tried,
all without success. It is perhaps worthwhile to mention two
of these unsuccessful models, one in which the active state
was a dimer, and another in which the apparent on- or off-
rate constants depended on the bound peptide concentration,
which could conceivably hide some of the PG and hinder
peptide binding at the later stages.
Since the all-or-none models failed for POPC/POPG
80:20, we tested the model proposed for the graded release
induced by the peptide tp10 (55). In this model, the peptide
causes dye efflux concomitantly with crossing the bilayer, as
a response to the mass imbalance across the membrane,
which is produced by the binding of the peptide itself.
When the peptide concentrations bound on both sides of
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explains the small fractions of dye release. The model was
described in detail before (55), and it is illustrated in Fig. 2
(right). Not to give this model any advantage, we also re-
stricted all fit parameters in the same manner as for the all-
or-none model, leaving only the rate constants k*ins and kdins,
which characterize the process of crossing the membrane, to
be fitted. After preliminary fits, we further fixed k*ins ¼ 0.6
M1 s1 for all concentrations and allowed only kdins to vary;
thus, the number of variable parameters was the same as for
the all-or-none model. The graded model was able to fit the
efflux curves for all lipid concentrations of POPC/POPG
80:20 with the same kdins, both for the direct and reverse
experiments, as shown by the solid lines in Fig. 8, E and
F. These results demonstrate the importance of the reverse
experiment in discriminating between models.
In conclusion, the all-or-none kinetic model is valid for
magainin when the membrane contains at least 30 mol %
PG. When only a small amount of PG exists in the membrane
(%20 mol %), magainin seems to follow a graded kinetic
model. The possible reason for this different behavior is
discussed below.
DISCUSSION
Magainin binding to membranes
We found that magainin binds to POPC/POPG LUVs in
a completely reversible manner. This is in agreement with
one of the earliest experiments, in which Grant et al. (15)
added unloaded to loaded PS SUVs where magainin 2a
had been allowed to act. They wrote: ‘‘leakage stopped
almost instantly after injection of unloaded vesicles.’’ In
our experiments, the on-rate constants for POPC/POPG
(Table 1) are essentially at the diffusion limit, which is
~106 M1 s1, expressed in terms of lipid concentration,
or ~1011 M1 s1 in terms of vesicles (LUVs). The kon
increases 10-fold from pure POPC to POPC/POPG 50:50,
but from POPC/POPG 80:20 to 50:50 kon increases only
slightly with anionic lipid content (Fig. 5 A). On the other
hand, koff decreases exponentially with POPG content, by
more than two orders of magnitude from pure POPC to
POPC/POPG 50:50 (Fig. 5 B). The equilibrium binding af-
finity increases by three orders of magnitude from pure
POPC to POPC/POPG 50:50. Clearly, the anionic lipid con-
tent of the vesicles plays a major role in magainin binding.
Does anionic lipid also matter for its activity and mecha-
nism? Interaction of magainin-2 with PG and PC membranes
has been shown to be different (63), but it could all be a
matter of binding differences.
The binding affinity of magainin to lipid membranes has
been examined by various authors and varies significantly
with the lipid system used. A summary of dissociation con-
stants from the literature is presented in Table 2. Binding of
magainin 2a variants to POPC/POPG 3:1, measured by SUV
Biophysical Journal 96(1) 116–131titration, increases with peptide hydrophobicity, whereas
selectivity for charged membranes decreases with increasing
peptide hydrophobicity (20). Wenk and Seelig (64) deter-
mined, by ITC, that magainin 2a binds to POPC/POPG 3:1
SUVs with DH ¼ 17 kcal/mol-peptide and DG ¼ 8
kcal/mol at 25C. Subtraction of the electrostatic component
yielded an estimate for the bare binding to neutral vesicles of
KDz 20 mM, corresponding toDG¼4.8 kcal/mol. Direct
measurement of binding of magainin 2a by ITC to POPC
SUVs yielded DH ¼ 17 kcal/mol and DG ¼ 7 kcal/
mol at 25C (42). Most important, the isotherms are hyper-
bolic in both POPC (20) and POPC/POPG 3:1 (at <7 mM
magainin) (64), with no trace of cooperativity, arguing
against magainin oligomerization.
Mechanism of dye release: graded or all-or-none?
The nature of dye release induced by magainin was ad-
dressed by Grant et al. (15), who found all-or-none release
from PS SUVs. Matsuzaki et al. (18) initially reported that
magainin 2 (þ4 charge) causes graded release from PG
LUVs, but later (17) that F12W-magainin 2, which behaves
similarly to magainin, causes all-or-none release from
PC/PG 1:1 (egg) LUVs. Further, two magainin variants,
with charges of þ2 and þ6, appear to function in all-or-
none and graded manners, respectively (17). All-or-none re-
lease from PC/PG 1:1 LUVs was also observed by Dempsey
et al. (61) and more recently by Tamba and Yamazaki (60),
who showed that magainin 2 causes all-or-none calcein re-
lease from GUVs of DOPC/DOPG 1:1. In that study, the
onset of release from each GUV was stochastic but, once
started, proceeded rapidly to completion. There were no
apparent changes in the vesicle, nor any micellization or
TABLE 2 Summary of literature data for binding of magainin
peptides to lipid vesicles
Peptide KD Lipid membrane Ref. Footnotes
Magainin-1 2.5 mM PS (bovine brain) SUV (14) *
Magainin 2a 5 mM POPG LUV (29) y
F12W-magainin 2 30 mM PS/PC 2:1 (brain/egg) LUV (19) z
F12W-magainin 2 30 mM PG/PC 2:1 (egg) LUV (19) x
Magainin 2a 50 mM POPC/POPG 3:1 LUV (29) {
Magainin 2a 100 mM POPC/POPG 3:1 SUV (64) k
Magainin 2a 200 mM POPC SUV (42) **
Magainin 2a 20 mM ‘‘Bare’’ neutral SUV (64) yy
Magainin 2a 2.5 mM POPC LUV (29) zz
F12W-magainin 2 10 mM Egg PC LUV (82) xx
*From initial rates of calcein leakage.
yFrom initial rates of calcein leakage.
zFrom Trp fluorescence.
xFrom Trp fluorescence.
{From dye release kinetics; similar for SUVs.
kFrom ITC.
**From ITC; the value is for 22C, interpolated from the temperature-depen-
dent data in Wieprecht et al. (42).
yyFrom ITC, after subtraction of the electrostatic component.
zzFrom dye release kinetics.
xxFrom Trp fluorescence.
Mechanism of Magainin 2disintegration. At low magainin concentration (3–5 mM)
some vesicles were observed to release all their contents,
whereas others released none. At>7 mM peptide, all vesicles
released all contents, but at <1–2 mM, all resisted (60).
Thus, although most published results indicated all-or-
none release by magainin, some uncertainty persisted, partic-
ularly if lipid or magainin version varied. Since the
mechanism of dye release is an intrinsic component of the
model for the quantitative analysis of efflux kinetics, it was
critical to be absolutely sure about it. We found that magai-
nin 2 causes all-or-none release from vesicles of POPC/
POPG 50:50 and 70:30 (Fig. 6), but for POPC/POPG
80:20, the situation is not clear.
Finally, in the cases of cecropin A (1) and magainin 2 (this
work), the average number of peptides bound per vesicle is
very large, of ~1000. Therefore, all-or-none release cannot
be explained in the same manner as for cases where the
average number of peptides bound per vesicle is very small,
of approximately the number of peptides necessary to form
a pore (65,66). In that case, vesicles that have fewer than
the average number of peptides bound cannot form a pore
and release nothing, while vesicles that have more release
all contents. This explanation is not valid here because all
vesicles have a much larger number of peptides bound
than is necessary to form a pore; the all-or-none character
of the release is, instead, a consequence of the stochastic
nature of pore formation.
Test of models for dye release kinetics
We tested whether the all-or-none kinetic model previously
proposed for cecropin A (1) (Fig. 2, left) could describe
the kinetics of dye efflux induced by magainin 2. Earlier
attempts at quantitatively modeling magainin-induced efflux
kinetics were made, although they were not as rigorous as
this one. In a very interesting article, Grant et al. (15)
observed that the kinetics of dye efflux induced by magainin
2 were not simple first-order; a fast initial phase (~100 s) was
followed by a slower one. Several models were proposed
(15), some quite complicated, but not analyzed in detail.
Matsuzaki et al. (18) suggested that a pore-deactivating
process may be responsible for the efflux kinetics not being
first-order, and that a transient pore could relax the peptide
concentration imbalance across the bilayer. Magainin 2 ef-
flux data very similar to ours was published (67); however,
the models used to describe the efflux kinetics included nei-
ther an explicit binding step nor an explicit pore formation
step (18,67). That is, the vesicles were treated as if they be-
gan at time zero with an equilibrium concentration of bound
peptides and an equilibrium density of pores, as if both the
establishment of binding equilibrium and pore formation
were instantaneous on the timescale of the efflux kinetics.
This assumption is reasonable for binding because the corre-
sponding equilibrium is established in ~0.1 s (Fig. 3). How-
ever, the assumption of instantaneous pore formation is notacceptable; to compensate for the missing pore formation
step, those models yielded peptide oligomerization.
In our experiments the rate of CF efflux increases with the
P/L ratio (Fig. 8), in agreement with the results of Matsuzaki
et al. (18). The most important conclusion we reach here is
that the same model (Fig. 2, left) originally proposed for ce-
cropin A (1) quantitatively describes efflux kinetics induced
by magainin 2 from vesicles of POPC/POPG 50:50 and
70:30 (Fig. 8). Except for one, all parameters were either
fixed at the same values used for cecropin A (rate constants
for efflux and pore formation) or determined in independent
experiments (on- and off-rate constants). Only the parameter
b needs to be varied, which gives the ratio of the rate con-
stants for pore formation and relaxation. The values of
b for magainin 2 are ~0.2–0.4 of those for cecropin A, indi-
cating that the magainin-2 pore state is less efficient. (This
could be because the pore is smaller, forms slower or closes
faster, or a combination of the three.) However, magainin 2 is
more sensitive to anionic lipid, as b increases ~5 from
POPC/POPG 70:30 to 50:50. A quantitative fit of the efflux
kinetics was obtained for both peptides, suggesting a com-
mon mechanism. That such a simple model fits almost all
data for cecropin A and magainin 2 suggests, furthermore,
that their mechanisms are not that complicated. The model
does not include peptide dimerization, and alternatives that
included this step performed much worse in quantitatively
fitting the data. Dimerization of a magainin analog
(F5Y,F16W double mutant) has been observed by NMR
(43). However, this was obtained under very special condi-
tions—very high peptide (5 mM) and lipid (0.5 mM) concen-
tration on DLPC SUVs, which are strained, and not very
stable, phospholipid bilayers. The relevance of that dimer
structure to the biological function of magainin remains to
be demonstrated.
In POPC/POPG 80:20, the mechanism appears to be
graded based on the efflux kinetics analysis, though a conclu-
sive answer could not be obtained from the ANTS/DPX as-
say. The situation in this lipid mixture is probably special
and not very representative of the general mechanism be-
cause the peptide on the surface nearly saturates the POPG
lipid. We conjecture that this may lead to the agglutination
of those lipids and formation of domains with a very high
peptide density, where the perturbation of the membrane is
localized. Membrane disruption may occur locally, concom-
itant with peptide translocation to the vesicle interior. This
results in graded and limited efflux, in accordance with the
same model proposed for tp10 (55) (Fig. 2, right). It is pos-
sible that domain formation also occurs, albeit to a lesser ex-
tent, upon addition of magainin to membranes of POPC/
POPG 50:50 and 70:30, which could change the efflux kinet-
ics. This could be the reason for the slight discrepancy be-
tween the initial portion of some fits and the data for those
two mixtures (Fig. 8, A and C). However, the effect must
be smaller than for POPC/POPG 80:20. This assertion is
corroborated by a previous study of domain formation in
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of synaptotagmin I, which shows that induction of PS
domains goes through a maximum (68). The reason is that
at high PS/C2, there is plenty of PS to satisfy all the C2 pro-
teins, whereas at low PS/C2, the same protein binds more
than one PS and agglutinates it. However, we would like
to caution against a definitive interpretation of the results
for POPC/POPG 80:20 because, as the percent release is
small in this case, the dynamical range of the CF efflux ex-
periment and its discriminatory power are also smaller.
The mechanism of magainin
The all-or-none kinetic model (1) is entirely consistent with
what is known about the mechanism of magainin. With
reference to Fig. 2 (left), at low peptide concentration on the
membrane (state B), magainin is oriented parallel to the mem-
brane surface (4,26,28,34,36) and the vesicles remain tight
(60). The peptides cause bilayer thinning (6,32,69,70) and
positive curvature strain (19,39). Eventually, as more peptides
bind, a point of rupture is reached where the bilayer yields, al-
lowing the contents to leak out all at once (state C). The pores
seem to form and reseal stochastically and independently,
without a concerted transition from a surface-associated to
an inserted peptide state. A concerted transition would result
in the appearance of cooperativity, which is completely absent
from the dye release kinetics. Consistent with this, measure-
ment of magainin 2a binding to POPC and POPC/POPG
SUVs by ITC yielded hyperbolic isotherms (below 7mM
magainin) with no indication of cooperativity (42,64). Rather,
as specifically incorporated in our model (1), the peptides in
a pore state catalyze efflux from lipid vesicles in proportion
to the concentration of that state on the membrane.
Our results do not lead to a structural description of these
pores, but provide constraints that molecular models pro-
posed as mechanisms for these peptides must satisfy. First,
the formation of stable pores can be ruled out. The fraction
of peptides in the pore state must be small because they read-
ily desorb from the vesicles. One set of values of kon and koff
is sufficient to quantitatively describe all the data for binding
(Fig. 3), dissociation (Fig. 4), and CF efflux kinetics (Fig. 8).
When magainin was prebound to empty vesicles and then
mixed with CF-loaded vesicles (reverse experiment, Fig. 8,
bottom panels) the CF efflux rates were almost identical to
those obtained by direct mixing with the loaded vesicles. If
stable pores were to form, desorption must be slow because
it would be limited by the rate of pore disassembly. The
fraction of magainin in pores, estimated by OCD, is <50%
in DMPC/DMPG 3:1 even at P/L as high as 1:20 (4), which
is also in agreement with NMR and infrared data
(26,28,33,34,36). Furthermore, our results indicate that no
oligomerization or dimerization occurs, which would be
required for any channel-type pore.
Second, formation of very transient pores is also inconsis-
tent with the data. That would lead to graded efflux because
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out, leaving some dye still inside. Thus, the sinking raft
model or very short-lived perturbations can be excluded. If
peptides formed a pore that then disassembled, there should
be approximately equal probabilities for the peptides to
translocate to the inner monolayer or to return to the outer
monolayer of the membrane. Then, the amount of peptide
dissociation after preincubation with donor vesicles in the
reverse experiment, as well as its rate, should significantly
decrease, but this is not observed in POPC/POPG 50:50
and 70:30 (Fig. 8, B and D). Dissociation from vesicles
should also be slower, but to a first approximation the koff de-
termined from binding and dissociation kinetics (Table 1) are
essentially identical, indicating little translocation. However,
we do notice that the values of koff are systematically smaller
in the dissociation experiments, though only by a factor of
~2. More important, the dissociation kinetics are somewhat
biphasic (Fig. 4), requiring double-exponential fits, whereas
single exponentials are sufficient for the association kinetics.
This may reflect limited translocation of the peptide upon
pore formation, but it must be significantly <50% because
the all-or-none kinetic model quantitatively fits the CF efflux
data for POPC/POPG 50:50 and 70:30, and translocation is
not incorporated in the model. Evidence for translocation
of magainin 2 was obtained using vesicles asymmetrically
labeled with lipid fluorophores (71), but the experimental
results that appear to indicate peptide translocation could
also be caused by lipid flip-flop. Matsuzaki et al. (71) argued
that vesicle leakage occurs simultaneously with transloca-
tion, but only ~20% of the peptides appear to have translo-
cated in the timeframe of those experiments. This level of
translocation would be consistent with our results.
The carpet model (72,73), in its most general form, postu-
lates that peptides bind to the membrane and lie parallel to
the surface until a threshold concentration is reached. This
is consistent with our results. Membrane perturbation of an
unspecified kind, which includes formation of transient
pores, can then occur. If the peptide concentration increases
to high values (not reached in this investigation), severe
membrane disruption may occur. But at no stage do stable
pores exist. Unfortunately, many pictures of the carpet model
show extensive membrane coverage culminating in micelli-
zation. This gives the impression that surface coverage is
required, which is clearly not the case for magainin 2 and
also not essential for the carpet model.
What, then, is the molecular conformation of the mem-
brane in this pore state that leads to all-or-none dye release?
It could be a bilayer with one or more large toroidal pores
(69,70,74–76). The stochastic nature of the all-or-none ki-
netic model lies in the random formation of pores in the
membrane. In the absence of peptide, formation of a lipid-
lined pore is associated with a high free energy (77) and is
therefore a very rare event. The presence of the peptides
makes those events more frequent. In this sense, the peptide
acts as a catalyst, lowering the activation free energy for
Mechanism of Magainin 2 129efflux. We envision this happens through the effect of the
peptides on the elastic properties of the bilayer and, possibly,
by direct stabilization of the pores, as proposed by Lee et al.
(69) and Huang (70) for antimicrobial peptides and specifi-
cally for magainin, following the ideas formulated by Bro-
chard-Wyart et al. (74), Karatekin et al (75), and Puech
et al. (76) for other systems. Our model is basically in agree-
ment with these ideas, but the orientation and localization of
the peptides when the vesicles reach the chaotic pore state
are probably much less well defined than usually proposed
for a toroidal pore (6).
Formation and relaxation of toroidal pores in a bilayer
under mechanical stress has been observed in molecular dy-
namics simulations (78,79). Molecular dynamics simulations
of a magainin analog interacting with a PC membrane indi-
cate a disorganized structure of the pore and the peptides
associated with it (80). We view these simulations as quali-
tative models and, as such, they provide interesting ideas for
plausible mechanisms. The analysis presented here, on the
other hand, demonstrates that the agreement of the all-or-
none kinetic model with the experimental data is not only
qualitative but quantitative. Furthermore, the model is the
same as for cecropin A, and, because it is quantitative, it con-
stitutes a predictive tool for other cases. More tests are in
progress in our laboratory. The pore structure that corre-
sponds to this model may apply to a variety of antimicrobial
peptides. Thus, determination of the structure of these pores,
at a detailed molecular level, which has not been achieved so
far for any peptide, remains a major challenge in structural
biophysics.
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